1887

Chapter 13.7 : I C L

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

I C L, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap13.7-1.gif /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap13.7-2.gif
There is no abstract provided for this chapter. We are in the process of generating a full text preview. Please bookmark and return later.
Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 13.7.4–1
Figure 13.7.4–1

Medical alert card.

Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818814.chap13.7
1. US Department of Labor. 2013. Bloodborne pathogens. Standard 1910, OSHA regulation 1910.1030(f)(l) and 1910.1030(f)(2), Occupational Safety and Health Administration, Washington, DC. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table= standards&p_id=10051. Accessed 7 November 2015.
2. Public Health Agency of Canada. Material safety data sheets and risk assessment. Public Health Agency of Canada, Ottawa, Ontario, Canada. http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php. Accessed 7 November 2015.
3. Atkinson WL. 1994. Measles and healthcare workers. Infect Control Hosp Epidemiol 15:57.
4. Centers for Disease Control and Prevention. 2011. Recommended adult immunization schedule, United States, 2011. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/vaccines/schedules/index.html. Accessed 7 November 2015.
5. Centers for Disease Control and Prevention. 2015. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 64:608612.
6. Centers for Disease Control and Prevention. 2011. Immunization of health-care personnel—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 60(RR-7):145.
7. Centers for Disease Control and Prevention. 2010. Use of anthrax vaccine in the United States—recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recommend Rep 59(RR- 6):130.
8. Centers for Disease Control and Prevention. 2001. Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 50(RR-10):125.
9. Centers for Disease Control and Prevention. 2008. Human rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recommend Rep 57(RR-3):126, 28.
1. Miller MJ, Astles R, Baszler T, Chapin K, Carey R, Garcia L, Gray L, Larone D, Pentella M, Pollock A, Shapiro DS, Weirich E, Wiedbrauk D. 2012. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, biosafety blue ribbon panel. MMWR Surveill Summ 61(Suppl):1102.
2. Fleming DO. 2006. Prudent biosafety practices, p 361–371. In Fleming DO, Hunt DL (ed), Biological Safety, 4th ed. ASM Press, Washington, DC.
3. Mermel LA, Josephson SL, Dempsey J, Parenteau S, Perry C, Magill N. 1997. Outbreak of Shigella sonnei in a clinical microbiology laboratory. J Clin Microbiol 35:31633165.
4. Centers for Disease Control and Prevention. Handwashing: Clean Hands Save Lives. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/handwashing/. Accessed 29 August 2013.
5. US Department of Labor. 2013. Bloodborne pathogens. Standard 1910, OSHA regulation 1910.1030(f)(1) and 1910.1030(f)(2), Occupational Safety and Health Administration, Washington, DC. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table= standards&p_id=10051. Accessed 7 November 2015.
1. Panlilio AL, Orelien JG, Srivastava PU, Jagger J, Cohn RD, Cardo DM, NaSH Surveillance Group; EPINet Data Sharing Network. 2004. Estimate of the annual number of percutaneous injuries among hospital-based healthcare workers in the United States, 1997-1998. Infect Control Hosp Epidemiol 25:556562.
2. Henderson DK. 2009. HIV in the healthcare setting, p 37533770. In Mandell GL, Bennett JE, Dolin R (ed), Principles and Practice of Infectious Diseases, 7th ed. Elsevier Churchill Livingston, New York, NY.
3. Centers for Disease Control and Prevention. 2001. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recommend Rep 50(RR-11):142.
4. Denys GA. 2010. Management of laboratory accidents, p 15.7.115.7.7. In Garcia LS (ed), Clinical Microbiology Procedures Handbook, 3rd ed. ASM Press, Washington, DC.
5. Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL, US Public Health Service Working Group. 2013. Updated U.S. Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 34:875892.
6. Centers for Disease Control and Prevention. 2011. Immunization of health-care personnel. MMWR Recommend Rep 60(RR-07):145.
21. CLSI. 2005. Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline, 3rd ed. Document M29-A3. CLSI, Wayne, PA.
22. Henderson DK. 2012. Management of needlestick injuries: a house officer who has a needlestick. JAMA 307:7584.
23. MacCannell T, Laramie AK, Gomaa A, Perz JF. 2010. Occupational exposure of health care personnel to hepatitis B and hepatitis C: prevention and surveillance strategies. Clin Liver Dis 14:2336.
24. New York State Department of Health AIDS Institute. 2012. HIV Prophylaxis following Occupational Exposure. New York State Department of Health AIDS Institute, New York, NY. http://www.hivguidelines.org/clinical-guidelines/post-exposure-prophylaxis/hiv-prophylaxis-following-occupational-exposure/. Accessed 17 June 2013.
1. Sewell D. 2004. Laboratory safety, p 446472. In Garcia LS (ed), Clinical Laboratory Management. ASM Press, Washington, DC.
2. Delany JR, Pentella MA, Rodriguez JA, Shah KV, Baxley KP, Holmes DE, Centers for Disease Control and Prevention. 2011. Guidelines for biosafety laboratory competency: CDC and the Association of Public Health Laboratories. MMWR Surveill Summ 60(Suppl 2):123.
3. Code of Federal Regulations. 1993. Part 1910. Occupational Safety and Health Standards. Subpart I. Personal Protective Equipment. Standard number 1910.134. Respiratory Protection. https://www.osha.gov/pls/osha web/owadisp.show_document?p_table= STANDARDS&p_id=12716.
4. Code of Federal Regulations. 1991. Part 1910. Occupational Safety and Health Standards. Subpart Z. Toxic and Hazardous Substances. Standard number 1910.1030. Blood-borne pathogens. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table= STANDARDS&p_id=10051.
5. Miller MJ, Astles R, Baszler T, Chapin K, Carey R, Garcia L, Gray L, Larone D, Pentella M, Pollock A, Shapiro DS, Weirich E, Wiedbrauk D. 2012. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, biosafety blue ribbon panel. MMWR Surveill Summ 61(Suppl):1102.
1. Centers for Disease Control and Prevention (CDC). 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS publication no. (CDC) 21-1112. US Government Printing Office, Washington, DC.
2. International Organization for Standardization. 2003. ISO 15190:2003. Medical Laboratories—Requirements for Safety. International Organization for Standardization, Geneva, Switzerland. http://www.iso.org.
3. World Health Organization. 2003. Laboratory Safety Manual. World Health Organization, Geneva, Switzerland. http://www.who.int/publications.
4. US Department of Transportation-Federal Motor Carrier Safety Administration (FMCSA). 2013. Hazardous Materials Safety. US Department of Transportation, Washington, DC. http://www.fmcsa.dot.gov/files/docs/Nine_Classes_of_Hazardous_Materials.pdf.
5. US Department of Transportation. How to Comply with Federal Hazardous Materials Regulations. US Department of Transportation, Washington, DC. http://www.fmsca.dot.gov/regulations/hazardous-materials/how-comply-federal-hazardous-materials-regulations.
6. US Government. 2013. Electronic Code of Federal Regulations. 2013. Federal Hazardous Materials Regulations—49 CFR Parts 100-185. US Government Publishing Office, Washington, DC. http://www.ecfr.gov.
7. United Nations. 2007. United Nations Recommendations on the Transport of Dangerous Goods. Model Regulations, 15th ed. http://www.unece.org/trans/danger/publ/unrec/rev15/15files_e.html). United Nations, New York, NY.

Tables

Generic image for table
Table 13.7.4–1

High-risk pathogenic agent considerations

Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7
Generic image for table
Untitled

Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7
Generic image for table
SYMPTOM MONITORING LOG

SYMPTOM MONITORING LOG

Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7
Generic image for table
Table 13.7.5–1

Biological pathogens that may be encountered in clinical specimens or during diagnostic testing that require increased laboratory containment

Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7
Generic image for table
Table 13.7.5–2

Assignment of laboratory isolation code to specimens suspected or confirmed to contain a biosafety risk group iii or iv pathogen

Citation: Leber A. 2016. I C L, p 13.7.1.1-13.7.5.5. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch13.7

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error